Developments in virus-like particle-based vaccines for HIV.

Expert Rev Vaccines

Department of Experimental Oncology, Molecular Biology and Viral Oncology Unit, Istituto Nazionale Tumori 'Fond Pascale', Via Mariano Semmola 142, 80131 Napoli, Italy.

Published: February 2013

Virus-like particles (VLPs) hold great promise for the development of effective and affordable vaccines. VLPs, indeed, are suitable for presentation and efficient delivery to antigen-presenting cells of linear as well as conformational antigens. This will ultimately result in a crosspresentation with both MHC class I and II molecules to prime CD4(+) T-helper and CD8(+) cytotoxic T cells. This review describes an update on the development and use of VLPs as vaccine approaches for HIV.

Download full-text PDF

Source
http://dx.doi.org/10.1586/erv.12.152DOI Listing

Publication Analysis

Top Keywords

developments virus-like
4
virus-like particle-based
4
particle-based vaccines
4
vaccines hiv
4
hiv virus-like
4
virus-like particles
4
particles vlps
4
vlps hold
4
hold great
4
great promise
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!